ecancer is hosting a live expert debate on the latest in chronic lymphocytic leukaemia:
Watch ecancer's expert discussion live, with audience interaction.
The panel members will be: Paula Cramer (Germany), Robin Foà (Italy), Steve Coutre (USA), and Constantine Tam (Australia).
The expert panel will review the data presented during the XVI International Workshop on Chronic Lymphocytic Leukaemia (iwCLL) with a particular focus on the B-cell receptor and the novel agents that target the BCR-signalling pathways.
After viewing this broadcast, you should be able to discuss the role of agents that target the B-cell receptor signalling pathways in the management of patients with CLL
Broadcast live from the 7th iwCLL meeting, being held in Sydney, Australia
Register here to view the debate live on 7th September at 11:00 BST, 10:00 GMT, 11:00 CET, 6:00am EST, 3:00am PST
iwCLL is being held in the Southern Hemisphere and the Asia-Pacific region and it is not to be missed by anyone with an interest in CLL.
XVI iwCLL 2015 will be the culmination of a major pivotal year for CLL with emerging novel data from B-cell receptor inhibitor and apoptosis induction agents, maintenance therapy trials, trials in the elderly, and the ongoing molecular revolution that will change the course of CLL biology and therapy globally.
The scientific program for the workshop will hold interest for all, with an exciting selection of speakers from around the globe discussing all aspects of CLL including workshops and special focus sessions.
We are an independent charity and are not backed by a large company or society. We raise every penny ourselves to improve the standards of cancer care through education. You can help us continue our work to address inequalities in cancer care by making a donation.
Any donation, however small, contributes directly towards the costs of creating and sharing free oncology education.
Together we can get better outcomes for patients by tackling global inequalities in access to the results of cancer research.
Thank you for your support.